Coalition of State and Territory Attorneys General Support Bipartisan Legislation to Prevent Youth Substance Use
The coalition of attorneys general stressed that youth substance use remains a growing public health and public safety concern—especially in light of the rise in fentanyl-related overdoses and the increasing availability of synthetic drugs.
Attorneys General Urge Congress to Preserve Access to Health Care for 9/11 Responders and Survivors
The coalition is calling on Congress to act swiftly and decisively to ensure WTCHP has the full funding it needs.
39 Attorneys General Urge Congress to Address Funding Crisis Affecting the World Trade Center Health Program
The coalition emphasizes the critical role of the LSC in ensuring that the legal system works for all Americans, particularly those who face economic barriers to adequate legal counsel.
State and Territory Attorneys General Urge FDA to Take Action Against Counterfeit and Illegally Sold GLP-1 Drugs
Washington, D.C.– The National Association of Attorneys General (NAAG) sent a letter on behalf of a bipartisan coalition of 38 state and territory attorneys general which calls on the Food and Drug Administration (FDA) to take decisive action against the unlawful sale and distribution of counterfeit and illegally sold GLP-1 drugs, including Mounjaro, Zepbound, Ozempic, and…
2022 NAAG Legislative Victories
As the chief legal officer of their state, attorneys general often provide important input on both regulatory and legislative proposals. This input is often provided through the National Association of Attorneys General (NAAG). As a nonpartisan organization, NAAG engages in policy advocacy only when an issue has bipartisan support from a majority of attorneys general….
NAAG Urges DEA and SAMSHA to Extend Telehealth Capabilities for Opioid Use Disorder Treatment
A bipartisan group of 45 state attorneys general urge the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) to permanently extend telehealth flexibilities after the expiration of the public health emergency for prescribing buprenorphine, one of three Food and Drug Administration (FDA) approved medications for treating opioid use disorder. Buprenorphine…
